Saturday, January 31, 2026

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Why North Korea Calls Russia’s Ukraine Attacks Self-Defense: Insights and Implications

North Korea defends Russia's airstrikes on Ukraine as self-defense, blaming the U.S. and NATO for the conflict's escalation.

Putin Thanks Kim as North Korean Troops Help in Kursk Fight

North Korea's media highlights housing developments, military support from Russia, and critiques of capitalism.

Tag: athlete

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.